- Alteplase, sold
under the
brand name
Activase among others, is a
biosynthetic form of
human tissue-type
plasminogen activator (t-PA). It is a thrombolytic...
-
RuBisCO activase promotes the
release of the
inhibitory (or — in some
views — storage) RuBP from the
catalytic sites of RuBisCO.
Activase is also required...
- non-functional
state if left uncarbamylated. A
specific activase enzyme,
called RuBisCo activase,
helps this
carbamylation process by
removing one proton...
-
children with
growth hormone deficiency (ceased
manufacturing 2004). 1987:
Activase (alteplase): A
recombinant tissue plasminogen activator (tPa) used to dissolve...
-
Urokinase Recombinant tissue plasminogen activators (rtPA)
Alteplase (
Activase or Actilyse)
Reteplase (Retavase)
Tenecteplase Anistreplase (Eminase) A...
-
after that
Vidara Therapeutics and
finally Horizon Pharma as of 2019.
Activase (alteplase), for
heart attacks.
Akynzeo (netupitant/palonosetron), for...
-
approval of
tissue plasminogen activator (also
known as tPA, t-PA, rtPA,
Activase, or
Alteplase or Actilyse) in the US and
other countries, and edaravone...
- Actin-N
Actimmune Actinex actinoquinol (INN)
Actiq Actisite actisomide (INN)
Activase Activella actodigin (INN)
Actonel Actos Actron ACU-Dyne
Acular Acutect...
- The
thrombolytic medication against myocardial infarction alteplase (
Activase) was
approved by the US Food and Drug
Administration in 1987. It was the...
-
carbamylation with CO2 and Mg2+ is blocked. The
functionality of
rubisco activase involves removing RuBP and
other inhibitory bonded molecules to re-enable...
